The effect of human placenta extract in wound healing model

Annals of Plastic Surgery

Volumn 65, Issue 1, 2010, Pages 96-100

  Hong, Jong Won ^a   Lee, Won Jai ^a   Hahn, Seung Boem ^a   Kim, Bom Jin ^b   Lew, Dae Hyun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b UP Plastic Clinics   (South Korea)

Author keywords

human placental extracts; TGF ; VEGF; wound healing

Indexed keywords

CD31 ANTIGEN; PLACENTA EXTRACT; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; DRUG EFFECT; HUMAN; INJURY; MALE; METABOLISM; MOUSE; PATHOLOGY; SKIN; WOUND HEALING;

ANIMALS; ANTIGENS, CD31; HUMANS; MALE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTAL EXTRACTS; SKIN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 77954243439     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e3181b0bb67     Document Type: Article

References (30)

1. Bozikov K, Arnez ZM. Factors predicting free flap complications in head and neck reconstruction. J Plast Reconstr Aesthet Surg. 2006;59:737-742.
2. Valentini V, Cassoni A, Marianetti TM, et al. Diabetes as main risk factor in head and neck reconstructive surgery with free flaps. J Craniofac Surg. 2008;19:1080-1084.
3. Ngo BT, Hayes KD, DiMiao DJ, et al. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol. 2005;6:225-237.
4. Ahmad TS, Musa G, Lee JK. A review of free flap failures in the University Hospital, Kuala Lumpur. Ann Acad Med Singapore. 1997;26:840-843.
5. Kessler P, Grabenbauer G, Leher A, et al. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma: Long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg. 2008;46:1-5.
6. Halle M, Bodin I, Tornvall P, et al. Timing of radiotherapy in head and neck free flap reconstruction - a study of postoperative complications. J Plast Reconstr Aesthet Surg. 2009;62:889-895.
7. Schultze-Mosgau S, Grabenbauer GG, Radespiel-Troger M, et al. Vascularization in the transition area between free grafted soft tissues and pre-irradiated graft bed tissues following preoperative radiotherapy in the head and neck region. Head Neck. 2002;24:42-51.
8. Schultze-Mosgau S, Rodel F, Radespiel-Troger M, et al. Vascularization of the area between free grafts and irradiated graft beds in the neck in rats. Br J Oral Maxillofac Surg. 2002;40:37-44.
9. Zheng Y, Yi C, Xia W, et al. Mesenchymal stem cells transduced by vascular endothelial growth factor gene for ischemic random skin flaps. Plast Reconstr Surg. 2008;121:59-69.
10. Schultze-Mosgau S, Wehrhan F, Rodel F, et al. Improved free vascular graft survival in an irradiated surgical site following topical application of rVEGF. Int J Radiat Oncol Biol Phys. 2003;57:803-812.
11. Mueller CK, Thorwarth MW, Schultze-Mosgau S. Angiogenic gene-modified fibroblasts for induction of localized angiogenesis. J Surg Res. 2009 Jan 3. 'Epub ahead of print.'
12. Ozawa CR, Banfi A, Glazer NL, et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 2004;113:516-527.
13. Unger EF, Goncalves L, Epstein SE, et al. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am J Cardiol. 2000;85:1414-1419.
14. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438: 932-936.
15. Schultze-Mosgau S, Lee BK, Ries J, et al. In vitro cultured autologous pre-confluent oral keratinocytes for experimental prefabrication of oral mucosa. Int J Oral Maxillofac Surg. 2004;33:476-485.
16. Oh J, Takahashi R, Kondo S, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 2001;107:789-800.
17. Spanholtz T, Maichle A, Niedworok C, et al. Timing and targeting of cell-based VEGF165 gene expression in ischemic tissue. J Surg Res. 2008; 151:153-162.
18. Elcin YM, Dixit V, Gitnick G. Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. Artif Organs. 2001;25:558-565.
19. Kim TK, Burgess DJ. Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model. J Pharm Pharmacol. 2002;54:897-905.
20. Sheridan MH, Shea LD, Peters MC, et al. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release. 2000;64:91-102.
21. King TW, Patrick CW Jr. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/ single emulsion/solvent extraction technique. J Biomed Mater Res. 2000;51: 383-390.
22. Laham RJ, Sellke FW, Edelman ER, et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation. 1999;100:1865-1871.
23. Popa ER, van der Strate BW, Brouwer LA, et al. Dependence of neovascularization mechanisms on the molecular microenvironment. Tissue Eng. 2007;13:2913-2921.
24. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288:669-672. (Pubitemid 30241569)
25. Krisky DM, Wolfe D, Goins WF, et al. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 1998;5:1593-1603.
26. Lubiatowski P, Goldman CK, Gurunluoglu R, et al. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Reconstr Surg. 2002;109:1986-1993.
27. Cristiano RJ. Viral and non-viral vectors for cancer gene therapy. Anticancer Res. 1998;18:3241-3245.
28. Rinsch C, Quinodoz P, Pittet B, et al. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther. 2001;8:523-533.
29. Zhang H, Zhu SJ, Wang W, et al. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther. 2008;15:40-48.
30. Yi C, Xia W, Zheng Y, et al. Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps. J Surg Res. 2006;135:100-106.